News & Updates

Show Multimedia Only
Machine learning predicts AF in heart failure patients

Machine learning predicts AF in heart failure patients

10 Nov 2023
Rosuvastatin on par with atorvastatin in CAD

Rosuvastatin on par with atorvastatin in CAD

06 Nov 2023 byStephen Padilla

Rosuvastatin is as effective as atorvastatin for the composite outcome of all-cause death, myocardial infarction (MI), stroke, or any coronary revascularization at 3 years in adults with coronary artery disease (CAD), according to the secondary analysis of the LODESTAR trial.

Rosuvastatin on par with atorvastatin in CAD

06 Nov 2023
Cefazolin beneficial in infective endocarditis caused by methicillin-susceptible S aureus

Cefazolin beneficial in infective endocarditis caused by methicillin-susceptible S aureus

06 Nov 2023
High red meat consumption increases risks of CVD and diabetes

High red meat consumption increases risks of CVD and diabetes

27 Oct 2023